<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: GSK raise annual profit forecast	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Wed, 05 Feb 2020 14:01:28 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: GlaxoSmithKline round off excellent 2019 with bullish fourth quarter update - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-14148</link>

		<dc:creator><![CDATA[GlaxoSmithKline round off excellent 2019 with bullish fourth quarter update - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 05 Feb 2020 14:01:28 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-14148</guid>

					<description><![CDATA[[&#8230;] October, the firm raised its annual profit forecast following a strong run of [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] October, the firm raised its annual profit forecast following a strong run of [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: GSK shares receive boost on US drug applicaton - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-13957</link>

		<dc:creator><![CDATA[GSK shares receive boost on US drug applicaton - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 27 Jan 2020 12:01:03 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-13957</guid>

					<description><![CDATA[[&#8230;] the end of October the FTSE100 listed firm then gave shareholders an impressive update which saw a lift in their annual profit forecasts as the firm impressively told shareholders that turnover rose 11% to £9.39 billion in the three [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the end of October the FTSE100 listed firm then gave shareholders an impressive update which saw a lift in their annual profit forecasts as the firm impressively told shareholders that turnover rose 11% to £9.39 billion in the three [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: GSK set to rival Johnson &#38; Johsnon for multiple myeloma drug - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-13260</link>

		<dc:creator><![CDATA[GSK set to rival Johnson &#38; Johsnon for multiple myeloma drug - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 17 Dec 2019 12:59:58 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-13260</guid>

					<description><![CDATA[[&#8230;] notably, GSK reported a lift in their lift in their annual profit forecasts as the firm impressively told shareholders that turnover rose 11% to £9.39 billion in the three [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] notably, GSK reported a lift in their lift in their annual profit forecasts as the firm impressively told shareholders that turnover rose 11% to £9.39 billion in the three [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Sanofi shares jump on narrow drug focus - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-13130</link>

		<dc:creator><![CDATA[Sanofi shares jump on narrow drug focus - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 10 Dec 2019 15:48:11 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-13130</guid>

					<description><![CDATA[[&#8230;] Rivals, such as FTSE100 (LON: GSK) listed GlaxoSmithKline (LON: GSK)  have also pledged to cut costs, and have also seen a period of strong trading. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Rivals, such as FTSE100 (LON: GSK) listed GlaxoSmithKline (LON: GSK)  have also pledged to cut costs, and have also seen a period of strong trading. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Sanofi announce purchase of US based Synthorx - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-13092</link>

		<dc:creator><![CDATA[Sanofi announce purchase of US based Synthorx - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 09 Dec 2019 14:55:15 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-13092</guid>

					<description><![CDATA[[&#8230;] Additionally, FTSE100 (INDEXFTSE: UKX) listed GlaxoSmithKline (LON: GSK) saw their shares in green after the firm lifted their annual profit forecast. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Additionally, FTSE100 (INDEXFTSE: UKX) listed GlaxoSmithKline (LON: GSK) saw their shares in green after the firm lifted their annual profit forecast. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Feedback Plc launches Bleepa pilot study - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-12661</link>

		<dc:creator><![CDATA[Feedback Plc launches Bleepa pilot study - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 18 Nov 2019 14:46:37 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-12661</guid>

					<description><![CDATA[[&#8230;] British rival GSK (LON: GSK) raised their annual profit forecast following a strong quarterly [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] British rival GSK (LON: GSK) raised their annual profit forecast following a strong quarterly [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Roche acquire US based pharmaceutical company Promedior - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-12627</link>

		<dc:creator><![CDATA[Roche acquire US based pharmaceutical company Promedior - UK Investor Magazine]]></dc:creator>
		<pubDate>Fri, 15 Nov 2019 14:15:32 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-12627</guid>

					<description><![CDATA[[&#8230;] PFE) smashed market and analyst expectations in their most recent update, whilst GSK (LON: GSK) lifted their annual profit forecast back in [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] PFE) smashed market and analyst expectations in their most recent update, whilst GSK (LON: GSK) lifted their annual profit forecast back in [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Concepta shares slide despite new CEO appointment - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-raise-annual-profit-forecast/#comment-12621</link>

		<dc:creator><![CDATA[Concepta shares slide despite new CEO appointment - UK Investor Magazine]]></dc:creator>
		<pubDate>Fri, 15 Nov 2019 12:52:36 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23291#comment-12621</guid>

					<description><![CDATA[[&#8230;] A few weeks back it was reported that Pfizer  (NYSE: PFE) had smashed market expectations in their most recent update, and British listed GSK (LON: GSK) raised their annual forecast following a bullish quarterly update. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] A few weeks back it was reported that Pfizer  (NYSE: PFE) had smashed market expectations in their most recent update, and British listed GSK (LON: GSK) raised their annual forecast following a bullish quarterly update. [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
